多囊卵巢综合征门诊用药分析
Analysis of Drug Use in Outpatient of Polycystic Ovary Syndrome

目的：深入了解某三甲医院多囊卵巢综合征门诊用药情况以协助临床合理用药。方法：通过医院信息查询系统的处方查询板块，收集2023年1月1日~12月31日诊断为多囊卵巢综合征的处方，并利用Excel的筛选对患者的性别和年龄，治疗药物的类别、使用频次、联用情况、价格、给药途径进行综合统计分析。结果：某院治疗多囊卵巢综合征前三位分别是性激素类药物(81.30%)、二甲双胍(15.20%)、中成药(13.00%)，其中性激素类药物中最常使用的是地屈孕酮片(51.17%)、戊酸雌二醇片(25.71%)和屈螺酮炔雌醇片(22.51%)。结论：治疗多囊卵巢综合征的药物的使用频次跟价格、给药途径、疗效、不良反应、病人的耐受程度都有很大的关联，在选择用药时，发挥联合用药的优势，采取个体化治疗的方案，使患者能得到精准治疗的同时，最大程度地提高安全性。
Objective: To investigate the drug use of polycystic ovary syndrome (PCOS) in outpatient department of a third class hospital in order to assist rational drug use in clinic. Methods: The prescriptions of patients diagnosed with PCOS from January 1 to December 31, 2023 were collected through the prescription query section of the hospital information query system, and the gender and age of the patients, the category of therapeutic drugs, the frequency of use, the combination of drugs, the price and the route of administration were comprehensively analyzed by Excel. Result: The top three drugs in the treatment of Pcystic ovary syndrome in a hospital were sex hormone drugs (81.30%), metformin (15.20%) and Chinese patent medicine (13.00%), among which the most commonly used sex hormone drugs were dydrogesterone tablets (51.17%), estradiol valerate tablets (25.71%) and drospirosterone ethinylestradiol tablets (22.51%). Conclusion: The frequency of use of drugs for the treatment of PCOS is closely related to price, route of administration, efficacy, adverse reactions and patient tolerance. In the selection of drugs, the advantages of combination medication should be given full play and individualized treatment plan should be adopted, so that patients can get accurate treatment and improve safety to the greatest extent.